Loading...
Symbols:
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
Transcripts
- Alnylam Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
- eHealth, Inc. Q3 2008 Earnings Call Transcript
- MIPS Technologies, Inc. F1Q09 (Qtr End 09/30/08) Earnings Call Transcript
- Alexza Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
- Alkermes, Inc. F2Q09 (Qtr End 09/30/08) Earnings Call Transcript
- Akorn, Inc. Q3 2008 Earnings Call Transcript
- Energy XXI (Bermuda) Limited F1Q09 (Qtr End 09/30/08) Earnings Call Transcript
- The Advisory Board Company F2Q09 (Qtr End 09/30/08) Earnings Call Transcript
- Thomas Weisel Partners Group, Inc. Q3 2008 Earnings Call Transcript
- The9 Q3 2008 Earnings Call Transcript
-
Editors' Picks
-
Most Popular
- General Electric: Genuine Risk of Collapse?
- Food: Against Self-Sufficiency
- The Fed: Now the World's Largest Private Bank
- Key to the Global Equity Market: Trend and Cycle Analysis of U.S. Retail
- Can a Global Economy Be Managed One Nation at a Time?
- Global Markets Week in Review: Turbulent Times
- Full list of Editors' Picks »
- Jim Rogers on China »
- Memo to Warren: AmEx Preferred at 15%, Warrants at $12 »
- Should We Really Bail Out the Big Three Automakers with $73.20 Per Hour Labor? »
- Peak Oil's Bell Is Ringing »
- UltraShort ETFs: At a Tipping Point? »
- The Biggest Problem Detroit's Big Three Face »
- 11 Stocks Selling Below Cash »
- Tech May Be a Wreck, But This Isn't 2001 »
- The Autos and Mentality That Ruined Detroit »
- Iceland: What It's Like to Live in a World Without Money »
- Wall Street Breakfast: Must-Know News »
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
Ginger Yellow
3 Comments
Interview with Joseph Mason: No True Sale with Prime Brokers, Hedge Funds
There has been a lot of mud thrown at securitisation in general that would more properly directed toward abuses of securitisation and the people who carried out and condoned those abuses. It's entirely possible to have a securitisation market that doesn't create perverse incentives, as long as investors and regulators are vigilant to ensure that lenders and structurers act responsibly.
"Thirdly, investors need to be able to connect bonds sold in the securitizations with the other related bond and securities that provide their credit support. You need to know how much of a given deal your paper represents and how much of the rest of the deal supports your paper."
I'm not sure what he's saying here. It's not at all difficult to find out how much subordination you have - it's in the offering circular, in the marketing materials and in the pre-sale report.
Monoline Duoline Rescue Plan: 5th Time the Charm?
Well, S&P puts Ambac'scurrent capital shortfall at just $400m, so in principle there's no reason why $3bn wouldn't be enough to save its AAA rating (assuming Moody's is roughly of the same opinion). Of course, whether or not it's enough to restore investor confidence is another matter.
Should BMO Be Worried About Moody's Valuation of Its SIV Exposure?
Secondly, the $1.25bn BMO invested was senior debt, not capital notes. The NAV calculation is relevant, because it provides a measure of the credit enhancement for senior debt, but it does not serve as a proxy for the value of the senior debt (whereas it does for the value of the capital notes).